Henry M Jackson Foundation For The Advancement Of Military Medicine is located in Bethesda, MD. The organization was established in 1983. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 09/2021, Henry M Jackson Foundation For The Advancement Of Military Medicine employed 3,079 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Henry M Jackson Foundation For The Advancement Of Military Medicine is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2021, Henry M Jackson Foundation For The Advancement Of Military Medicine generated $569.6m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 3.0% each year. All expenses for the organization totaled $552.2m during the year ending 09/2021. While expenses have increased by 2.7% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
WITH THE MISSION TO ADVANCE MILITARY MEDICINE, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC (HJF) IS A GLOBAL NONPROFIT ORGANIZATION PROVIDING INVESTIGATORS AND CLINICIANS SCIENTIFIC, ADMINISTRATIVE AND PROGRAM MANAGEMENT SERVICES. HJF SERVES AS A TRUSTED AND RESPONSIVE LINK BETWEEN THE MILITARY MEDICAL COMMUNITY, FEDERAL AND PRIVATE PARTNERS, AND THE MILLIONS OF AMERICAN SERVICE FAMILIES , VETERANS AND CIVILIANS WHO BENEFIT FROM THE MEDICAL RESEARCH ADVANCES THAT RESULT FROM THIS WORK.
Describe the Organization's Program Activity:
AS TRUSTED PARTNERS WITH MILITARY MEDICAL RESEARCHERS, IMPORTANT HJF ACCOMPLISHMENTS INCLUDE ATTRACTING, MANAGING, AND RETAINING HIGHLY QUALIFIED SCIENTIFIC STAFF TO SUPPORT THE PRIORITIES OF U.S. MILITARY MEDICINE. WHETHER IT IS THE SENIOR SCIENTIST TO LEAD MAJOR INITIATIVES AND WORK COLLABORATIVELY WITH U.S. GOVERNMENT SCIENTISTS, OR LAB TECHS TO PERFORM ONGOING RESEARCH FUNCTIONS, HJF HIRES THE BEST AND BRIGHTEST TALENT TO ACCELERATE INNOVATIONS NECESSARY TO ADVANCE MILITARY MEDICINE. HJF'S WORK IN FY2021 BROUGHT ADVANCES IN BATTLING THE COVID-19 PANDEMIC. HJF TEAMS PLAYED A VITAL ROLE IN SUPPORTING RESEARCH PROGRAMS FOCUSED ON COVID-19 VACCINES AND TREATMENTS SINCE MARCH 2020, BASED ON DECADES OF EXPERIENCE INVESTIGATING INFECTIOUS DISEASES WORLDWIDE. OTHER RESEARCH INITIATIVES WIDENED HJF'S REACH ACROSS GEOGRAPHIC REGIONS, ENGAGED NEW PARTNERS, RESULTED IN PATENTED TECHNOLOGY, AND STRENGTHENED COLLABORATIONS ACROSS U.S. FEDERAL AGENCIES, UNIVERSITIES, NON-GOVERNMENTAL ORGANIZATIONS, AND PRIVATE INDUSTRY. SOME EXAMPLES OF THIS IMPORTANT WORK ARE DETAILED BELOW. HJF SCIENTISTS AND U.S. ACTIVE-DUTY INVESTIGATORS RAN SEVERAL SITES OF PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER CLINICAL TRIALS WHICH LOOKED AT PREVENTING COVID-19 AFTER EXPOSURE THROUGH THE USE OF LONG-ACTING ANTIBODY COMBINATIONS. HJF'S SCIENTIFIC AND PROGRAM MANAGEMENT STAFF PARTNERED WITH THE U.S. DEPARTMENT OF DEFENSE (DOD), ACADEMIA, GOVERNMENT, AND INDUSTRY TO RUN THESE VITAL STUDIES AND OTHERS, WITH A FOCUS ON FILLING CRITICAL GAPS IN INFORMATION AND IMPROVING PUBLIC HEALTH. HJF ASSISTED ANOTHER INFECTIOUS DISEASE MILITARY RESEARCH TEAM WITH THE DEVELOPMENT OF A COVID-19 VACCINE. THE RESEARCH TEAM COMPLETED PHASE I STUDIES OF THE COVID-19 VACCINE CANDIDATE AND ADDITIONAL ANIMAL STUDIES ON EMERGING VARIANTS OF CONCERN. HJF ALSO SUPPORTED THE DEVELOPMENT OF AN ADJUVANT, WHICH IS USED WITH THE COVID-19 VACCINE TO INCREASE THE IMMUNE RESPONSE. HJF RESEARCHERS AND SUPPORT STAFF WORKED WITH FEDERAL PARTNERS TO MAXIMIZE SERVICE MEMBER PERFORMANCE AND READINESS BY MODERNIZING EXPOSURE ASSESSMENT, RISK MITIGATION, AND RISK ASSESSMENT TO MAKE RISK-BASED DECISIONS, POLICIES, AND PROTECTION MEASURES. THIS PROGRAM USED A COMBINATION OF COMPUTATIONAL AND IN VITRO TECHNIQUES TO DEVELOP TOOLS ADDRESSING THE TOXICOLOGY AND UNDERLYING PHYSIOLOGICAL HEALTH CONDITION OF SERVICE MEMBERS TO PREDICT HUMAN HEALTH RISK ESTIMATES, HELPING TO DEFINE SAFER WORKING ENVIRONMENTS AND IMPROVED MISSION SUCCESS. ONE TOOL, A SMARTPHONE APP, LETS USERS PERFORM RAPID HAZARD SCREENING, EVEN WITHOUT CONNECTIVITY, TO QUICKLY ASSESS RISK IN THE FIELD AND DETERMINE NEXT STEPS. HJF IS THE COORDINATOR OF A CONSORTIUM THAT CONSISTS OF GOVERNMENT, NONPROFIT, ACADEMIA AND INDUSTRY PARTNERS DEDICATED TO IMPROVING SURVIVAL FOR PATIENTS WITH SEPSIS IN RESOURCE-LIMITED SETTINGS. HJF COLLABORATED WITH A U.S. MILITARY BRANCH TO ESTABLISH THE CONSORTIUM, SET RESEARCH PRIORITIES, ESTABLISH STRATEGIC PARTNERSHIPS, AND LEAD OVERALL PROGRAM IMPLEMENTATION. IN 2021, THE TEAM WORKED WITH COLLABORATORS INCLUDING A UNIVERSITY AND TWO MEDICAL DEVICE COMPANIES TO TEST THE TREATMENT OF PATIENTS BY REMOVING PATHOGENS FROM THEIR BLOOD. TRIALS TOOK PLACE IN MILITARY AND CIVILIAN HOSPITALS, WITH THE GOAL TO ELIMINATE VIRUSES, BACTERIA, AND SUBSTANCES THAT COULD CAUSE INFLAMMATORY RESPONSE TO INFECTIOUS DISEASES, SUCH AS COVID-19. A TEAM OF HJF STAFF BASED AROUND THE WORLD PROVIDED EXPERT OPERATIONAL SUPPORT TO LOCATE AND RECOVER THE REMAINS OF UNACCOUNTED-FOR DOD PERSONNEL FROM PAST CONFLICTS. HJF STAFF ROLES ON THIS PROJECT REFLECT A WIDE RANGE OF RESPONSIBILITIES, INCLUDING ARCHAEOLOGIST, HISTORIAN, PROGRAM MANAGER, DATABASE MANAGER, AND MORE. HJF'S INVESTIGATION AND RECOVERY EFFORTS CONSISTED OF SUPPORT FOR TERRESTRIAL AND UNDERWATER MISSIONS, INCLUDING WATER AND SOIL TESTING. IN ADDITION TO THE WORK PERFORMED BY THE TEAM, HJF COLLABORATED WITH A WIDE RANGE OF PARTNERS, INCLUDING UNIVERSITIES, NONPROFIT ORGANIZATIONS, AND OTHERS. HJF WORKED WITH A JOINT U.S. FEDERAL AGENCY COLLABORATION FOCUSED ON CREATIVE ARTS THERAPIES AS A HIGHLY EFFECTIVE WAY OF IMPROVING THE HEALTH, WELLNESS, AND QUALITY OF LIFE FOR MILITARY AND VETERAN POPULATIONS EXPOSED TO TRAUMA AS WELL AS THEIR FAMILIES AND CAREGIVERS. IN 2021, 18 CREATIVE ARTS THERAPISTS ON HJF'S TEAM WORKED IN THIS NETWORK, PROVIDING ART, MUSIC, WRITING AND DANCE/MOVEMENT THERAPIES, BOTH ON-SITE AND THROUGH TELEHEALTH ENGAGEMENTS DUE TO THE PANDEMIC. THESE THERAPISTS CAN BE FOUND IN A DOZEN LOCATIONS ACROSS THE NATION. IN FY21, HJF RECEIVED MORE THAN 200 NEW AWARDS, GRANTS, AGREEMENTS, OR CONTRACTS IN ADDITION TO THE MORE THAN 13,500 IT HAS ADMINISTERED SINCE 1983. HJF HAD MORE THAN 1,150 ACTIVE RESEARCH PROTOCOLS IN PROCESS DURING FY21 ACROSS 45 STATES AND 35 COUNTRIES, WITH APPROXIMATELY 3,000 TEAMMATES AT SITES ON FOUR CONTINENTS.
ENDOWMENTS DELIVERED SIGNIFICANT PROGRAM SERVICES AND SUPPORT TO THE UNIFORMED SERVICES UNIVERSITY FOR THE HEALTH SCIENCES (USU), PARTICULARLY FOR THE SCHOOL OF MEDICINE AND THE CLINICAL SCIENCES DEPARTMENT OF SURGERY AND DEPARTMENT OF DERMATOLOGY. PROGRAMS INCLUDE FELLOWSHIP GRANTS FOR GRADUATE STUDENTS STUDYING MILITARY MEDICINE AT USU. HJF FELLOWSHIP AWARDS PROVIDE TRAVEL, EDUCATION, AND TRAINING SUPPORT.
EDUCATION ACCOUNTS PROVIDED EDUCATIONAL, TRAINING, AND OTHER APPROVED INITIATIVES RELATED TO ADVANCING MILITARY MEDICINE. SAMPLES OF PROJECTS FUNDED THROUGH EDUCATIONAL INITIATIVES INCLUDE PROVISIONING OF TEXTBOOKS, TRAVEL TO MEDICAL CONFERENCES OR COURSES, AND SUPPORT FOR EXAMS OR MANUSCRIPT PUBLICATION. ONE SPECIFIC INITIATIVE PROVIDED LABORATORY SUPPLIES AND REAGENTS TO SUPPORT A STUDENT'S PHD THESIS RELATED TO IMPROVING UNDERSTANDING OF MALARIA TRANSMISSION, TO CONTRIBUTE TO THE ULTIMATE GOAL OF CONTROLLING AND ERADICATING MALARIA AND IMPROVING GLOBAL HEALTH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Name Not Listed Ex Officio Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
University Of California At San Francisco Research Services | 9/29/21 | $19,961,295 |
Makerere Universitywalter Reed Project Research Services | 9/29/21 | $12,332,112 |
Massachusetts General Hospital Research Services | 9/29/21 | $3,406,231 |
Signet Technologies Inc Research Services | 9/29/21 | $4,865,693 |
Windber Research Institute Research Services | 9/29/21 | $6,140,670 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $414,970 |
Related organizations | $0 |
Government grants | $549,141,118 |
All other contributions, gifts, grants, and similar amounts not included above | $612,896 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $550,168,984 |
Total Program Service Revenue | $1,853,778 |
Investment income | $20,458 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $1,555,858 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $16,083,897 |
Net Income from Fundraising Events | -$35,276 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $569,647,699 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $4,069,520 |
Compensation of current officers, directors, key employees. | $4,069,520 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $184,714,482 |
Pension plan accruals and contributions | $10,983,393 |
Other employee benefits | $35,913,901 |
Payroll taxes | $13,646,006 |
Fees for services: Management | $0 |
Fees for services: Legal | $1,858,415 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $216,081,573 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $12,122,996 |
Travel | $1,124,624 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $217,044 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $2,909,980 |
Insurance | $734,408 |
All other expenses | $3,770,183 |
Total functional expenses | $552,186,297 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,663,782 |
Savings and temporary cash investments | $41,875,852 |
Pledges and grants receivable | $128,765,458 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $9,648,162 |
Net Land, buildings, and equipment | $10,935,416 |
Investments—publicly traded securities | $48,842,153 |
Investments—other securities | $22,762,112 |
Investments—program-related | $0 |
Intangible assets | $5,483,774 |
Other assets | $0 |
Total assets | $269,976,709 |
Accounts payable and accrued expenses | $83,051,263 |
Grants payable | $0 |
Deferred revenue | $11,231,283 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $19,612,061 |
Total liabilities | $113,894,607 |
Net assets without donor restrictions | $99,310,278 |
Net assets with donor restrictions | $56,771,824 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $269,976,709 |
Over the last fiscal year, we have identified 17 grants that Henry M Jackson Foundation For The Advancement Of Military Medicine has recieved totaling $7,381,035.
Awarding Organization | Amount |
---|---|
University Of Miami Coral Gables, FL PURPOSE: RESEARCH | $5,970,156 |
Denver Research Institute Denver, CO PURPOSE: MILITARY SUICIDE | $844,420 |
Fred Hutchinson Cancer Research Center Seattle, WA PURPOSE: VACCINE AND INFECTIOUS DISEASE | $294,166 |
Mayo Clinic Rochester, MN PURPOSE: SUPPORT CHARITABLE PROGRAMS | $49,594 |
Cystic Fibrosis Foundation Bethesda, MD PURPOSE: CF CARE CENTER | $47,500 |
Tracys Kids Inc Bethesda, MD PURPOSE: to support the Tracy's Kids art therapy program | $31,827 |
Beg. Balance | $40,099,623 |
Earnings | $11,307,923 |
Net Contributions | $16,665 |
Other Expense | $2,202,656 |
Ending Balance | $49,221,555 |
Organization Name | Assets | Revenue |
---|---|---|
Henry M Jackson Foundation For The Advancement Of Military Medicine Bethesda, MD | $269,976,709 | $569,647,699 |
Commonwealth Foundation For Cancer Research Foundation Richmond, VA | $31,990,703 | $16,751,552 |
Usagainstalzheimers Washington, DC | $8,313,876 | $12,845,054 |
The Association For Frontotemporal Degeneration King Of Prussia, PA | $44,796,969 | $12,057,958 |
Childrens Oncology Group Foundation Philadelphia, PA | $22,837,173 | $7,487,855 |
Accelerate Brain Cancer Cure Inc Washington, DC | $0 | $1,166,711 |
Fox Chase Cancer Center Foundation Philadelphia, PA | $63,333,365 | $6,307,847 |
Urology Care Foundation Inc Linthicum, MD | $76,869,441 | $7,067,880 |
Hope For Henry Foundation Washington, DC | $2,134,104 | $1,677,257 |
American Foundation For Children With Aids Inc Harrisburg, PA | $518,393 | $1,638,509 |
The Childrens Cancer Foundation Inc Columbia, MD | $1,439,343 | $1,526,844 |
The Naspghan Foundation Ambler, PA | $6,522,780 | $1,880,637 |